1. Signaling Pathways
  2. Neuronal Signaling
    Protein Tyrosine Kinase/RTK
  3. Trk Receptor
  4. Trk Receptor Antagonist

Trk Receptor Antagonist

Trk Receptor Antagonists (2):

Cat. No. Product Name Effect Purity
  • HY-12497
    ANA-12
    Antagonist 99.90%
    ANA-12 is a potent and selective TrkB antagonist with IC50s of 45.6 nM and 41.1 μM for the high and low affinity sites, respectively.
  • HY-P99221
    Tanezumab
    Antagonist 99.52%
    Tanezumab (RN-624) is a humanized anti-NGF mAb with high affinity and specificity. Tanezumab blocks NGF binding to its receptors, p75 and TrkA, in the peripheral nervous system. Tanezumab can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia.